Switch theme
Sign up to access all valuation multiples
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina’s high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
1998
10.4K+
LTM Revenue $4.4B
LTM EBITDA $1.2B
$16.3B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Illumina has a last 12-month revenue of $4.4B and a last 12-month EBITDA of $1.2B.
In the most recent fiscal year, Illumina achieved revenue of $4.4B and an EBITDA of -$725M.
Illumina expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Illumina valuation multiples based on analyst estimates| FY 2022 | FY 2023 | FY 2024 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $4.6B | $4.5B | $4.4B | $4.4B | XXX |
| Gross Profit | $3.0B | $2.7B | $2.9B | XXX | XXX |
| Gross Margin | 65% | 61% | 65% | XXX | XXX |
| EBITDA | -$3.9B | -$608M | -$725M | $1.2B | XXX |
| EBITDA Margin | -85% | -13% | -17% | 27% | XXX |
| Net Profit | -$4.4B | -$1.2B | -$1.2B | XXX | XXX |
| Net Margin | -96% | -26% | -28% | XXX | XXX |
| Net Debt | $724M | $441M | $862M | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of February 21, 2025, Illumina's stock price is $94.
Illumina has current market cap of $14.9B, and EV of $16.3B.
See Illumina trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $16.3B | $14.9B | XXX | XXX | XXX | XXX | $4.21 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of February 21, 2025, Illumina has market cap of $14.9B and EV of $16.3B.
Illumina's trades at 3.7x LTM EV/Revenue multiple, and 13.9x LTM EBITDA.
Analysts estimate Illumina's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Illumina and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $16.3B | XXX | XXX | XXX |
| EV/Revenue | 3.7x | XXX | XXX | XXX |
| EV/EBITDA | -22.5x | XXX | XXX | XXX |
| P/E | -12.2x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | 23.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpIllumina's NTM/LTM revenue growth is 0%
Illumina's revenue per employee for the last fiscal year averaged $0.4M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, Illumina's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Illumina's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Illumina and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -3% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -17% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 19% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | -16% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.4M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 27% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 52% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| ToolGen | XXX | XXX | XXX | XXX | XXX | XXX |
| 4basebio | XXX | XXX | XXX | XXX | XXX | XXX |
| Genus | XXX | XXX | XXX | XXX | XXX | XXX |
| Oryzon Genomics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Illumina acquired XXX companies to date.
Last acquisition by Illumina was XXXXXXXX, XXXXX XXXXX XXXXXX . Illumina acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Illumina founded? | Illumina was founded in 1998. |
| Where is Illumina headquartered? | Illumina is headquartered in United States of America. |
| How many employees does Illumina have? | As of today, Illumina has 10.4K+ employees. |
| Who is the CEO of Illumina? | Illumina's CEO is Mr. Jacob Thaysen. |
| Is Illumina publicy listed? | Yes, Illumina is a public company listed on NAS. |
| What is the stock symbol of Illumina? | Illumina trades under ILMN ticker. |
| When did Illumina go public? | Illumina went public in 2000. |
| Who are competitors of Illumina? | Similar companies to Illumina include e.g. EZZ Life Science, ToolGen, 4basebio, Genus. |
| What is the current market cap of Illumina? | Illumina's current market cap is $14.9B |
| What is the current revenue of Illumina? | Illumina's last 12-month revenue is $4.4B. |
| What is the current EBITDA of Illumina? | Illumina's last 12-month EBITDA is $1.2B. |
| What is the current EV/Revenue multiple of Illumina? | Current revenue multiple of Illumina is 3.7x. |
| What is the current EV/EBITDA multiple of Illumina? | Current EBITDA multiple of Illumina is 13.9x. |
| What is the current revenue growth of Illumina? | Illumina revenue growth between 2023 and 2024 was -3%. |
| Is Illumina profitable? | Yes, Illumina is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
